Italy's AI Law establishes new criminal offenses, creating meaningful risks for US executives and employees. The law ...
Shares in PepGen were down more than 21% after the FDA placed a partial clinical hold on its lead drug PGN-EDODM1, for rare ...
Hansa had asked the FDA to consider a priority review of its biologics licensing application (BLA) for imlifidase, which was ...
Cardiff, Wales-based Antiverse's computational platform has been set up to find antibodies against challenging drug targets, ...
Lilly will make its Zepbound KwikPen (tirzepatide) – which delivers four weekly injections in one device – available through the programme at a cost of $449 across all doses for an individual patient, ...
They found that after three years of follow-up, the group taking GLP-1 agonists like Novo Nordisk's semaglutide and Eli Lilly's tirzepatide were 14% less likely to develop substance use disorders ...
What emerged through such discussions was not optimism nor was it pessimism, but clarity. The consensus was striking in its consistency across sessions. JPM 2026 signalled genuine recovery – but not ...
Arbutus and Genevant's complaint claimed that Moderna's mRNA-based Spikevax shot used lipid nanoparticle (LNP) delivery technology, which enables the safe and effective delivery of nucleic acid ...
The study analysed two years of search ads linked to Ozempic.com. An estimated $7.5m was spent on 15,000+ keywords, ...
The UK government is providing nearly £50 million in funding for equipment that it says will help the NHS carry out ...
The latest phase of the long-running scheme – run by Cancer Research UK (CRUK) and the National Cancer Institute (NCI) in the ...
The pharmaceutical industry is racing to turn its data into scientific intelligence with AI. Now, it’s possible to connect your data and tool ecosystem. There is a gold rush happening in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results